Gladstone Institutes Newsroom

A new study uses large-scale genetic approach to uncover human genes controlling HIV infection.

Machine, Meet Stem Cells

The biotech company MedaRed, Inc. is founded on groundbreaking basic research from Gladstone Institutes, UC San Francisco, and UC San Diego

Insight into how three of the world's most devastating viruses interact with human cells opens the door for much-needed treatments

A team of scientists from the Gladstone Institutes, UCSF, and UC Berkeley identify nearly 200 potential drug targets

Gladstone scientists show how a type of neuron improves procedural learning.

Study from the Gladstone Institutes may lead to new treatments for diseases like multiple sclerosis

A new center at Gladstone aims to find unforeseen uses for existing drugs

The discovery could improve treatments for autoimmune diseases and cancer

Cells related to seizures, schizophrenia and ADHD all found in the same region of the brain

Gladstone scientists identify inflammatory pathways as a potential therapeutic target for frontotemporal dementia

Deepak Srivastava, MD, led a team who created mouse models of CAVD that may be used to test drug therapies for the disease.

With $4.8 million from the NIH, Gladstone scientists will investigate how the protein apoE4 causes neurodegeneration in Alzheimer's disease.

NIH award supports collaborative work to discover the connection between neurovascular dysfunction and cognitive decline in Alzheimer's disease.

Benoit Bruneau is selected to lead the Gladstone Institute of Cardiovascular Disease

Study by Gladstone scientists finds blood protein destroys memory storage sites in the brain and may lead to new treatments

The NIH funds an initiative at the Gladstone Institutes to assess the safety of CRISPR-like therapies in human tissues

BioMotiv and Cure Network Dolby Acceleration Partners collaborate to advance the development of better treatments for brain disorders

Study will use innovative technology to focus on neurodegenerative diseases

Scientists develop a cheaper, quicker, and more reliable stem cell-based technology to facilitate drug discovery

An unexpected collaboration leads to the discovery of an early predictor of IBD

Gladstone investigator is elected VP of the preeminent organization dedicated to stem cell research and treatments

Gladstone scientists uncovered a possible strategy to "shock and kill" the virus that hides in cells

Lipofuscis deposits accumulate in the retina of patients carrying mutations in the progranulin protein linked to neurological diseases.

New study shows potentiating a subset of NMDA receptors may be beneficial in Alzheimer's disease and Dravet syndrome.

New study shows how patterns in brain activity can be an early predictor of Alzheimer's symptoms

Gladstone researchers Warner C. Greene and Eytan Herzig collaborated with Xyphos Biosciences, Inc., to develop a novel immunotherapy for HIV.

An unexpected brain region is important for Dravet Syndrome, finds study from the Gladstone Institutes

Scientists from the Gladstone Institutes discover how to enhance the longevity of cells that kill tumors and infected cells

Different routes of sexual transmission affect the immune system's response to a virus, shows new study.

New study explains what happens when the immune system ages

The term begins on January 1, 2018

A single drug could attack the virus on two fronts

Researchers show that semen amyloids help the human body dispose of excess and defective sperm

Gladstone scientists show that a cancer drug is effective in treating common causes of heart failure

Gladstone scientists are the first to produce a type of stem cell-derived neuron that could potentially help restore movement

A long time supporter of the Institutes, Price is the sixth trustee in Gladstone's 37-year history